Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Myriad Genetics Inc.

NAS: MYGN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Myriad Genetics Inc.

After Hours

MYGN
/zigman2/quotes/208126816/composite

$

20.00

Change

+1.14 +6.04%

Volume

Volume 248,564

Feb 8, 2023, 7:48 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208126816/composite

Previous close

$ 19.59

$ 18.86

Change

-0.73 -3.73%

Day low

Day high

$18.85

$20.17

Open
Open: 19.43

52 week low

52 week high

$13.92

$28.18

Open

Market cap

$1.59B

Average volume

759,295

P/E ratio

N/A

Rev. per Employee

$275,583

EPS

-0.96

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mygn

MarketWatch News on MYGN

  1. Myriad Genetics upgraded to outperform from market perform at Raymond James

    7:30 a.m. Jan. 18, 2023

    - Tomi Kilgore

  2. Thematic ETFs Look Tempting. Just Say No.

    4:01 p.m. Dec. 12, 2022

    - Barron's Online

  3. Myriad Genetics initiated at market perform at Raymond James

    6:47 a.m. June 15, 2021

    - Tonya Garcia

  4. Myriad Genetics Stock Is Jumping. Earnings Were Great.

    7:07 a.m. May 4, 2021

    - Barron's Online

  5. Myriad Genetics stock price target cut to $14 from $17 at J.P. Morgan

    6:36 a.m. March 6, 2020

    - Tomi Kilgore

  6. Myriad Genetics Stock Is Tanking After Earnings. The CEO Is Out.

    8:59 a.m. Feb. 7, 2020

    - Barron's Online

  13. Uber Stock, Shake Shack Are Falling as the Dow Chugs Ahead Again

    7:49 a.m. Nov. 5, 2019

    - Barron's Online

  14. Myriad Genetics Stock’s Wild Ride Will Continue, Analyst Says

    10:35 a.m. Sept. 26, 2019

    - Barron's Online

  15. Myriad Genetics downgraded to underperform from neutral at BofA Merrill Lynch

    9:04 a.m. Sept. 26, 2019

    - Tomi Kilgore

  16. Myriad Executives Sold Stock Before Shares Plunged

    11:59 a.m. Sept. 4, 2019

    - Barron's Online

  17. Myriad Genetics Runs Into Trouble With the F.D.A.

    7:26 p.m. Aug. 16, 2019

    - Barron's Online

  20. Myriad Genetics Craters on Weak Earnings, FDA Scrutiny

    7:56 a.m. Aug. 14, 2019

    - Barron's Online

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mygn

Other News on MYGN

  4. CareDx: Organ Transplant Business Falters In Q3

    2:40 p.m. Nov. 11, 2022

    - Seeking Alpha

  6. Myriad Genetics: All You Need To Know About Q3 Earnings

    1:37 a.m. Nov. 3, 2022

    - Seeking Alpha

  7. 10-Q: MYRIAD GENETICS INC

    3:11 p.m. Nov. 2, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  10. MNSO and CLEU among mid-day movers

    12:40 p.m. Nov. 1, 2022

    - Seeking Alpha

  13. Myriad Genetics Q3 2022 Earnings Preview

    11:14 a.m. Oct. 31, 2022

    - Seeking Alpha

  15. OncoCyte: FDA's Regulatory Arm Might Pressure This Microcap

    7:00 a.m. Oct. 26, 2022

    - Seeking Alpha

  17. Here's Why Investors Should Hold Myriad Genetics (MYGN) Now

    10:35 a.m. Sept. 26, 2022

    - Zacks.com

  18. Myriad: Trying To Find Its Footing In An Evolving Industry

    6:05 a.m. Sept. 26, 2022

    - Seeking Alpha

  19. Invitae Busted Business Model Offers A Tactical Opportunity

    12:05 p.m. Sept. 23, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/mygn

Press Releases on MYGN

  16. Myriad Genetics Reports Third Quarter Financial Results

    8:05 a.m. Nov. 1, 2022

    - GlobeNewswire

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.